[Federal Register Volume 73, Number 102 (Tuesday, May 27, 2008)]
[Notices]
[Page 30418]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-11631]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 25, 2008, Siegfried 
(USA), Inc., Industrial Park Road, Pennsville, New Jersey 08070, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of Oripavine(9330), a basic class 
of controlled substance listed in schedule II.
    The company will use the above listed controlled substance in the 
manufacture of other controlled substance intermediates for sale to its 
customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administration, Office of Diversion Control, Federal Register 
Representative (ODL), Washington, DC 20537, or any being sent via 
express mail should be sent to Drug Enforcement Administration, Office 
of Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than July 28, 2008.

    Dated: May 15, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E8-11631 Filed 5-23-08; 8:45 am]
BILLING CODE 4410-09-P